Navigation Links
Sanofi-aventis Commences Tender Offer for All Outstanding Shares of Chattem, Inc.
Date:1/11/2010

PARIS, Jan. 11 /PRNewswire-FirstCall/ -- Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today the commencement of a tender offer through its wholly-owned subsidiary, River Acquisition Corp., for all outstanding shares of common stock of Chattem, Inc. (Nasdaq: CHTT) for $93.50 per share, net to the seller in cash, without interest and less any required withholding taxes. The tender offer is being made pursuant to an Offer to Purchase, dated January 11, 2010, and in connection with the previously announced Agreement and Plan of Merger, dated December 20, 2009, among sanofi-aventis, River Acquisition Corp. and Chattem, Inc.

The tender offer is scheduled to expire at 12:00 midnight, New York City time, on February 8, 2010, unless the tender offer is extended. The tender offer is conditioned on the tender of a majority of Chattem's shares calculated on a fully-diluted basis (as defined in the Agreement and Plan of Merger), as well as the receipt of certain regulatory approvals and other customary closing conditions. Following the successful completion of the tender offer, sanofi-aventis' wholly-owned subsidiary, River Acquisition Corp., will merge with and into Chattem and the outstanding Chattem shares not tendered in the tender offer will be converted into the right to receive the same $93.50 per share in cash paid in the tender offer.

The transaction is a significant milestone in sanofi-aventis' transformational strategy. By strengthening its presence in the U.S. consumer healthcare market, which represents 25 percent of the current worldwide opportunity, sanofi-aventis is further securing its position as a global, integrated healthcare company and building a significant platform for future growth.'/>"/>

SOURCE Sanofi-aventis
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Sanofi-aventis to Acquire Chattem Inc., Creating a Strong U.S. Consumer Healthcare Platform
2. Intelliject, Inc. Enters Into Licensing Agreement with sanofi-aventis for U.S./Canada Rights to Novel Epinephrine Auto-injector
3. Sanofi-aventis U.S. and Intelliject, Inc. Sign Licensing Agreement for Novel Epinephrine Auto Injector in North America
4. Sanofi-aventis: Multaq(R) Approved in the European Union for Patients With Atrial Fibrillation
5. Sanofi-aventis and Regeneron Expand Strategic Antibody Collaboration
6. Prasco Enters into Agreements with sanofi-aventis U.S. to Provide Sales Support and Distribution Services for Authorized Generic Versions Under the Winthrop Label in U.S.
7. Sanofi-aventis and Merrimack Pharmaceuticals Enter Into a Worldwide Collaboration and Licensing Agreement on MM-121, an Anti-ErbB3 Monoclonal Antibody
8. Fovea Pharmaceuticals to be Acquired by sanofi-aventis
9. Sanofi-aventis Stands Behind the Safety of Lantus(R)
10. Insulin Analogues From Novo Nordisk, Eli Lilly and Sanofi-Aventis Will Drive Growth in the Type 1 Diabetes Drug Market
11. Vical Licensee Sanofi-aventis Initiates Phase 3 Trial to Reduce Amputations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... , Feb. 27, 2015  Two ... increasing in applications as their effectiveness is ... Kalorama Information.  Kalorama Information says that while ... the most powerful tool in proteomic biomarker ... MS) through its traditional techniques has struggled ...
(Date:2/26/2015)... Ill. , Feb. 26, 2015  AbbVie ... 15 abstracts of studies in its neuroscience and ... during the 67 th American Academy of ... , from April 18-25. The accepted abstracts ... DUOPA, in addition to investigational treatments in AbbVie,s ...
(Date:2/26/2015)... 26, 2015  Mail-service and specialty pharmacies will ... and government health plans $23.3 billion over the ... Pharmaceutical Care Management Association (PCMA). "Home ... of the easiest ways to reduce health costs," ... . "Policymakers should resist efforts to restrict these ...
Breaking Medicine Technology:Report: "Softer" Mass Spec Techniques Gaining Popularity in Biomarker Discovery 2Report: "Softer" Mass Spec Techniques Gaining Popularity in Biomarker Discovery 3AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 2AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 3AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 4AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 5AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 6AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 7PCMA: Report Shows High-Tech Specialty and Mail-Service Pharmacies Will Reduce Costs for Texas Employers, Consumers and Public Programs by $23.3 Billion 2
(Date:2/27/2015)... Victorian Hotel recently celebrated Valentine’s Day ... wanted to spend the auspicious day together. This Vancouver ... jump on Valentine’s Day with a sweet overnight package, ... their luxurious rooms. , The hotel started its ... a mouthwatering 3 course meal at Café 335. This ...
(Date:2/27/2015)... The UC Davis Huntington’s Disease Center, ... it a beacon of hope for people with Huntington’s ... by the national society committed to the values that ... of America — as a Level 1 Huntington’s Disease ... center’s service to over 300 families coping with Huntington's ...
(Date:2/27/2015)... “ Logical Operations ” was featured ... which takes a look at the latest and coolest ... a special reporter for NewsWatch and a technology expert, ... company helps companies avoid cyber security threats. , If ... see cyber security somewhere in the headlines. Well, cyber ...
(Date:2/27/2015)... Mirena IUD lawsuits ( http://www.mirenalawsuit2014.com/ ) ... perforations and other serious harm due to spontaneous migration ... in the multicounty litigation underway in New Jersey’s Bergen ... records indicate that the proceeding’s 34th Case Management Order ... that same day. (In Re: Mirena Litigation; Case No. ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 Jupiter Medical ... pioneering partnership, Mount Sinai Heart New York at Jupiter ... research in South Florida. , “This innovative collaboration ... way we’re delivering unparalleled health care in our very ... Executive Officer of Jupiter Medical Center. “This kind of ...
Breaking Medicine News(10 mins):Health News:Victorian Hotel Celebrated Valentine’s Day in 2015 With Unique Overnight Deal 2Health News:UC Davis Huntington's Disease Center Receives Level 1 Designation 2Health News:UC Davis Huntington's Disease Center Receives Level 1 Designation 3Health News:A Way for Companies to Avoid Cyber Security Threats was Featured on NewsWatch Television on January 30, 2015 2Health News:Mirena Lawsuits Progress in New Jersey with Issuance of New Case Management Order, Bernstein Liebhard LLP Reports 2Health News:Mirena Lawsuits Progress in New Jersey with Issuance of New Case Management Order, Bernstein Liebhard LLP Reports 3Health News:Jupiter Medical Center and Mount Sinai Heart New York Announce Landmark Partnership 2Health News:Jupiter Medical Center and Mount Sinai Heart New York Announce Landmark Partnership 3Health News:Jupiter Medical Center and Mount Sinai Heart New York Announce Landmark Partnership 4Health News:Jupiter Medical Center and Mount Sinai Heart New York Announce Landmark Partnership 5
... 8-year-old boy,living with epilepsy, and his mother Amy receive ... the exclusive sponsor of Canine,Assistants seizure response dogs. Through ... to play sports, take,music lessons, and learn Tae Kwon ... when his parents are not around is still a ...
... quick, non-invasive identification of the dangerous disease , , WEDNESDAY, ... be able to accurately, rapidly, and non-invasively diagnose lung ... the mouth, a new study suggests. , Oral cavity ... to be a highly accurate indicator of similar lung ...
... Mass., April 16 Xceed Molecular, a ... analysis,systems, announced that the University of Florida ... work with primary researchers,Charles Joel Rosser, MD ... of Surgery), to perform initial verification and ...
... Required to Provide Calorie Information, ALEXANDRIA, Va., ... today,s federal court ruling upholding,a New York City ... content of foods on their menus and menu ... to the regulation filed by the New York ...
... MONICA, Calif., April 16 Consumer,Watchdog today joined ... lawsuit alleging that health insurer Blue Cross engaged ... insurance of patients,after they got sick., The ... at least hundreds,of patients who have been left ...
... 16 MedCath Corporation,(Nasdaq: MDTH ) announced today ... of Directors., Mr. Grossman brings a wealth of ... Directors. He served as partner and health care,practice leader ... years with the firm. While with Pricewaterhouse Coopers, he ...
Cached Medicine News:Health News:Young Boy With Epilepsy to Gain Independence With New Seizure Response Dog From Canine Assistants 2Health News:Mouth Swab May One Day Diagnose Lung Cancer 2Health News:Mouth Swab May One Day Diagnose Lung Cancer 3Health News:Xceed Molecular Signs University of Florida to Strategic Collaborator Program; Focus on Developing New Molecular Test to Diagnose Early-Stage Bladder Cancer 2Health News:Xceed Molecular Signs University of Florida to Strategic Collaborator Program; Focus on Developing New Molecular Test to Diagnose Early-Stage Bladder Cancer 3Health News:Statement of the American Diabetes Association Supporting Federal Court's Ruling on New York City Proposal 2Health News:Consumer Watchdog Applauds L.A. City Attorney's Efforts to Reinstate Cancelled Blue Cross Patients; Urges State HMO Regulator to Do Same 2Health News:Woodrin 'Woody' Grossman Appointed to MedCath's Board of Directors 2
... breadth of infectious disease ELISA products make ... standard assay protocols for faster integration into ... products provide increased reliability and run-to-run consistency. ... detection assays for a wide range of ...
... We offer a complete ... bringing laboratorians state-of-the-art monoclonal and ... the detection of enteric pathogens ... includes products for Clostridium difficile, ...
... The C. Difficile Tox A/B II ... Professional Diagnostics's exclusive Fecal-Quik-Prep device which greatly ... stool specimens for Tox A/B II testing. ... preparation/transfer device that greatly reduces the amount ...
... products for autoimmune testing feature single-well ANA ... as specific reflex tests including dsDNA, and ... (Ro), SS-B (La), Scl-70 and Jo-1. In ... full line of products for Cardiolipins (IgA, ...
Medicine Products: